Oxford University Innovation Patent - Genetic Delivery Composition
Summary
The European Patent Office published patent application EP4122498A1 for Oxford University Innovation Limited, covering a novel composition for delivery of genetic material. The patent, published March 25, 2026, includes IPC classifications related to pharmaceutical preparations, proteins, and genetic constructs. The patent is designated across 31 European states including major markets such as Germany, France, and the United Kingdom.
What changed
The European Patent Office granted Patent EP4122498A1 to Oxford University Innovation Limited for a genetic material delivery composition. The patent application, filed with inventors Seow, Alvarez, and Wood, covers compositions in IPC classes A61K 48/00 (medicinal preparations containing genetic material), C07K 14/705 (peptides), and C12N 15/113 (nucleic acid constructs). The designated states include all major EU member states as well as Switzerland, Norway, and other EPO member countries.
Pharmaceutical companies and biotechnology firms developing gene therapy products should review this patent to assess potential licensing requirements or freedom-to-operate implications. The patent grants exclusive rights to the disclosed delivery composition across 31 designated states. Entities conducting research in this technical space should conduct freedom-to-operate analyses to identify potential infringement risks.
What to do next
- Review patent EP4122498A1 for freedom-to-operate analysis in gene therapy development programs
- Assess licensing requirements if developing similar delivery compositions for commercial use
- Update IP portfolio tracking systems with new patent grant date of March 25, 2026
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITION FOR DELIVERY OF GENETIC MATERIAL
Publication EP4122498A1 Kind: A1 Mar 25, 2026
Applicants
Oxford University Innovation Limited
Inventors
SEOW, Yiqi, ALVAREZ, Lydia, WOOD, Matthew
IPC Classifications
A61K 48/00 20060101AFI20221219BHEP A61K 47/42 20170101ALI20221219BHEP C07K 14/705 20060101ALI20221219BHEP C07K 7/06 20060101ALI20221219BHEP C07K 14/005 20060101ALI20221219BHEP C07K 14/435 20060101ALI20221219BHEP C12N 15/11 20060101ALI20221219BHEP C12N 15/113 20100101ALI20221219BHEP A61K 47/69 20170101ALI20221219BHEP A61P 43/00 20060101ALI20221219BHEP
Designated States
AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
A free, real-time feed of regulatory changes from government agencies, regulators, and courts. Every change gets a permanent, citable page. Our mission
This page and its URL are permanent. We don't delete or silently edit change pages. Archival policy
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.